Position in EOLS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$581,565
-$357,228 QoQ
Shares Held
141,500
+0.2% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Potomac Capital Management, Inc. holds $581,565 across 1 Drug Manufacturers - Specialty & Generic name. EOLS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EOLS |
Evolus, Inc.
This page
|
141,500 | $581,565 |
All Filings in EOLS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $581,565 | 141,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $938,793 | 141,172 | Shares | Sole | 2026-02-11 | |
| 2023-12-31 | $1,630,538 | 154,847 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,415,301 | 154,847 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,125,737 | 154,847 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,405,206 | 166,100 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,247,411 | 166,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,336,300 | 166,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,579,920 | 136,200 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,525,920 | 136,000 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $862,575 | 132,500 | Shares | Sole | 2022-02-07 | |
| No filing history on record for this holder in this stock. | ||||||